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Dyggve-Melchior-Clausen dysplasia (DMC) and Smith-McCort dysplasia (SMC) are similar, rare autosomal recessive
osteochondrodysplasias. The radiographic features and cartilage histology in DMC and SMC are identical.However,
patients with DMC exhibit significant developmental delay and mental retardation, the major features that distin-
guish the two conditions. Linkage studies localized the SMC and DMC disease genes to chromosome 18q12-21.1,
providing evidence suggesting that they are allelic disorders. Sequence analysis of the coding exons of the FLJ90130
gene, a highly evolutionarily conserved gene within the recombination interval defined in the linkage study, identified
mutations in SMC and DMC patients. The affected individuals in two consanguinous DMC families were ho-
mozygous for a stop codon mutation and a frameshift mutation, respectively, demonstrating that DMC represents
the FLJ90130-null phenotype. The data confirm the hypothesis that SMC and DMC are allelic disorders and
identify a gene necessary for normal skeletal development and brain function.
Introduction
Dyggve-Melchior-Clausen dysplasia (DMC [MIM
#223800]) and Smith-McCort dysplasia (SMC [MIM
#607326]) are autosomal recessive osteochondrodyspla-
sia phenotypes (Smith and McCort 1958; Dyggve et al.
1962; Kaufman et al. 1971; Spranger et al. 1976) that
are classified together in the current nosology and clas-
sification of constitutional disorders of bone (Interna-
tional Nomenclature Group on Constitutional Disorders
of Bone, in press). The radiographic features of both
conditions include epiphyseal and metaphyseal irregu-
larity, platyspondyly with a double-humped appearance
of the vertebrae, and a characteristic lacy iliac crest.
Short stature is progressive and complications include
varus and valgus deformity at the knees, scoliosis, and
limitation in joint movement. Both disorders exhibit ab-
normal cartilage histology, with the growth plate show-
ing disordered chondrocyte columns that include degen-
erating cells and rough endoplasmic reticulum inclusions
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(Horton et al. 1982; Engfeldt et al. 1983; Nakamura et
al. 1997).
Linkage studies in SMC defined a 10.7-cM recom-
bination interval at 18q12 that is likely to contain the
disease gene (Ehtesham et al. 2002), and a similar in-
terval was identified in DMC (Ehtesham et al. 2002;
Thauvin-Robinet et al. 2002). Sequence analysis of the
coding exons of FLJ90130, a highly evolutionarily con-
served gene located within the interval defined in the
linkage studies, identified mutations in both DMC and
SMC families. These data demonstrate that DMC and
SMC are allelic disorders and identify a gene necessary
for normal skeletal development and brain function.
Subjects and Methods
Subjects
All families were ascertained by the International Skel-
etal Dysplasia Registry andwere collected after informed
consent was obtained under an approved institutional
review board protocol. Affected individuals presented
with characteristic clinical and radiographic (fig. 1) find-
ings. This included marked disproportionate short stat-
ure with a short barrel-shaped chest, kyphoscoliosis, and
joint limitation. The Dyggve-Melchior-Clausen dyspla-
sia patients showed developmental delay and mental re-
tardation, whereas the Smith-McCort dysplasia patients
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Figure 1 Left panel, Lateral view of the spine, showing platyspondyly and the characteristic double-humped appearance of the vertebral
bodies with anterior beaking. Right panel, Antero-posterior view of the hips, showing short, widened ilia with a lacy appearance of the iliac
crests. The acetabulae are hypoplastic and irregular. The proximal femoral necks are short, with irregular metaphyses and epiphyses.
were of normal intelligence. A more detailed clinical and
radiographic description of the Smith-McCort dysplasia
families is presented in an article by Burns et al. (in
press).
Mutation Analysis
Genomic DNA fragments containing the coding se-
quence and flanking splice-junction consensus sequences
of each exon were amplified by PCR. Primer sequences
are given in table 1. Amplified fragments were subjected
to sequence analysis using the ABI Prism Big Dye version
3 sequencing kit (Applied Biosystems), and the products
were separated by electrophoresis using an ABI model
377 automated DNA sequencer. Sequence data were
processed using ABI software and analyzed using
Sequencher.
RT-PCR
Total RNA from frozen cartilage was prepared by Tri-
zol extraction. Reverse transcription used 1 mg of the
total RNA, 100 ng random hexamers, Superscript re-
verse transcriptase and buffers from a kit under condi-
tions recommended by the manufacturer (Invitrogen).
Amplification used primers derived from exon 7 (5′-
TGTTTTCCTTTCCTGCCAAC-3′) and exon 9 (5′-
AGAGGGGAAGAAAGCTCTGG-3′). The cDNA frag-
ments were separated by agarose gel electrophoresis.
Results and Discussion
Sequence analysis was carried out for genes in the DMC/
SMC linkage interval (Ehtesham et al. 2002; Thauvin-
Robinet et al. 2002) in affected individuals from three
families with DMC and two families with SMC. There
were no mutations identified in either the coding exons
or flanking splice-junction consensus sequences of the
MADH2 (Ehtesham et al. 2002), MADH4, MADH7,
and TPMT genes, so structural mutations in these genes
were excluded as the cause of SMC and DMC.
Mutations were identified in the FLJ90130 gene in
all five families, and these were the only families studied.
FLJ90130 consists of 17 exons distributed over 1400
kb of genomic DNA. Features of the gene structure are
given in table 2. The initiating methionine codon was
identified in exon 2. Although the initiation codon was
in a poor Kozak consensus sequence (GAAGAUGG),
there was an in-frame stop codon 6 bp to the 5′ side,
supporting the identity of the AUG as the initiator. The
stop codon was in exon 17 and was followed by a
polyadenylation signal (AATAAA) 228 bp into the 3′
UTR. In the cDNA, the poly A followed 18 bp after
the polyadenylation signal. The cDNA encodes a
669–amino acid protein of unknown function, with an
implied molecular weight of 75,918 kDa. To identify
the mutations, primers were derived from the genomic
sequence for amplification and sequence analysis of the
coding exons (2–17) and flanking splice junctions.
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Table 1
Amplification of the FLJ90130 Exons
Exon
PCR
Product
Size
(bp) Primer Sequences
2 415 5′-GCCCCATATTTCTTGTAACTTTG-3′
5′-AATCAGCATACCACACAAGTTGA-3′
3 326 5′-TTCACTACTGTGCACCATATTTTTC-3′
5′-AGCATCTGTGAATGCCACAA-3′
4 279 5′-AGCAATTTTAATATGACATTTGGTTTT-3′
5′-CCACAGTCCATTTCCATCAA-3′
5 310 5′-CGGTTGTCAAATCAGGAAGAA-3′
5′-TCAAAATCATACTTTTATTCCTGAAA-3′
6 238 5′-GGAATGAAAATGTAACTTCTGAACAA-3′
5′-GGACCCACAAACTTCTCAACA-3′
7 336 5′-AGTGTCTTAATCTTCCAAAGTGACTG-3′
5′-TAGAATGCGGTTCCCTATGC-3′
8 394 5′-TGTGAGTTGTGCCAATAGCC-3′
5′-TGAACCAGCTGCACAAATTC-3′
9 283 5′-ATCTCATTGGTGGCAGCAC-3′
5′-AACAAGCAATACTCTCCCCATT-3′
10 351 5′-AATGGGAATTGAGTTGTACACATTAC-3′
5′-GCTGTGCCATGTACCCTAAAA-3′
11 328 5′-AAGCAAAGAGCACAAAATGAAA-3′
5′-GGTTCTCACAGGAACATCTACCA-3′
12 342 5′-CCTTCAGAGCAAAGTCATCGT-3′
5′-CAGTGACCGGTATTTTCTACCA-3′
13 245 5′-CAGTGACAACTGAGTTTACATTTGC-3′
5′-ATAGCTCAGCCAGAGGCAAA-3′
14 240 5′-CCACAGAAGACAGAAAAGAAAACA-3′
5′-TGGGATTACAGGCAGGAGTT-3′
15 369 5′-CTTCATGATCTTTCCAATGCTG-3′
5′-CAAGGCTTATTAAACATTCTCTGCT-3′
16 281 5′-CATGTGAGAAAGGCGGCTAC-3′
5′-AGCAGCATGATTCTGGATAGG-3′
17 533 5′-ACCACCTGCAAACTCTCACC-3′
5′-GCAACAGGATCTTGGGAAAG-3′
Table 2
Structure of the FLJ90130 Gene
Exon/Intron
Number
Exon
Size
(bp)a
Amino Acid
Residuesb
Splice
Donor
Splice
Acceptor
Intron
Size
(kb)c
1 GTGGGC TAG 29.3
2 193 1–47 GTAAGA CAG 38.6
3 53 48–64 GTAAGT CAG 11.8
4 94 65–96 GTAAGC TAG 1.0
5 133 97–140 GTAAGT CAG 15.3
6 73 141–165 GTAAGT TAG 29.3
7 126 166–207 GTATGT TAG 1.7
8 143 208–254 GTAAGT CAG 44.6
9 183 255–315 GTTTGT CAG 4.3
10 179 316–375 GTAAGT TAG 9.7
11 126 376–417 GTAAGT CAG 13.6
12 114 418–455 GTAAGT CAG 1.3
13 95 456–487 GTAAAT CAG 93.3
14 103 488–521 GTAAGT AAG 44.7
15 183 522–582 GTGAGT CAG 21.2
16 114 583–620 GTAAGA CAG 53.2
17 621–669
a The size of exon 1 is undetermined, as the 5′ nucleotide of
the gene has not been defined. Similarly, the 3′ nucleotide of
the transcript is undetermined, so the size of exon 17 is
uncertain.
b Where a codon is split between two exons, the amino acid
residue is included in the exon with two nucleotides of the
codon.
c The genome assembly for the region of chromosome 18
containing the FLJ90130 gene has not been finalized, so intron
sizes are approximate.
The affected individual in DMC family R94-187, a
consanguinous family originating in the Dominican Re-
public, was homozygous for a point mutation in exon
2 (CrG) that predicted a Y16X change (fig. 2a). Both
parents were carriers of the mutation, and the unaf-
fected child was homozygous for the normal sequence,
compatible with the chromosome 18 haplotypes inher-
ited from her parents (Ehtesham et al. 2002). The very
early truncation of the protein implied by the mutation
strongly suggests that the mutation is a null. Thus,
DMC appears to be the phenotype resulting from ab-
sence of the FLJ90130 gene product.
In family R02-106, which was affected with DMC,
the two affected individuals were homozygous for de-
letion of the last nucleotide of exon 8, predicting a
frameshift after codon 254 and a stop 9 codons further
downstream (fig. 2b). Cultured cells from the family
were not available, so it could not be determined if the
mRNA derived from the mutant allele was stable to
nonsense-mediated decay (Maquat 2000) or if the pre-
dicted truncated protein was synthesized and stable.
However, the marked truncation of the protein implied
by the mutation suggests that a truncated protein would
likely not be functional. Homozygosity for the mutation
was expected because the parents were first cousins and
the affected individuals were homozygous for markers
throughout the interval defined in the linkage studies
(Ehtesham et al. 2002). Both parents were carriers of
the mutation, and the unaffected child was also hetero-
zygous for the pathologic change.
In DMC family R96-219, the affected child was a
compound heterozygote. The first mutation was a
transversion in exon 5 (TrA) that predicted a Y132X
change (fig. 2c), presumably a null allele. This mu-
tation was inherited from the mother. The second
mutation, which was inherited from the father, was
a point mutation that predicted a N469Y missense
change (fig. 2c). Because we are unsure of the bio-
logical function of the protein and the roles of specific
amino acid residues in its activity, we cannot be ab-
solutely sure if this change is a pathological mutation.
However, no other sequence changes among the
FLJ90130 exons were identified. Furthermore, BLAST
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Table 3
Comparison of the FLJ90130 Protein
Sequence and Homologous Proteins
from other Species
Species
Identity
(%)
Similarity
(%)
M. musculus 94 96
C. elegans 37 55
D. melanogaster 42 61
A. gambiae 42 59
A. thaliana 31 53
Figure 2 Mutations in DMC. a, Chromatograms showing the mutation in family R94-187 and (below) a normal sequence. The sequence,
with the mutant nucleotide and the corresponding normal nucleotide identified with an arrow, is shown above, and the reading frame is
underlined. The nucleotide sequence is numbered from the beginning of the coding sequence. The pedigree, demonstrating segregation of the
mutation in the family, is shown to the right. b, Chromatograms showing the mutation in family R02-106, together with a normal sequence.
An arrow identifies the mutant nucleotide and the corresponding normal nucleotide, and the reading frame is underlined. A vertical line identifies
the exon-intron junction. Segregation of the mutation in the family is shown on the pedigree to the right. c, Chromatograms showing the two
mutations identified in family R96-219. The reading frame is underlined, and, in each panel, an arrow identifies the normal (above) and mutant
(below) sequences. Segregation of the mutations in the family is shown on the pedigree to the right.
analysis of the predicted FLJ90130 protein sequence
identified homologous proteins in other species (fig. 3;
table 3), including Mus musculus, Drosophila melan-
ogaster, Anopheles gambiae, Caenorhabditis elegans,
and Arabidopsis thaliana, and amino acid residue N469
was conserved among all of them. Residue 469 is also
within a region of the protein with very high cross-
species conservation. The evolutionary conservation,
from mammals to plants, suggests that residue 469 is
important and therefore that the N469Y substitution
could affect the function of the encoded protein. Be-
cause the patient has the more severe DMC phenotype,
it is likely that the mutation has a markedly detrimental
effect on protein function.
In SMC families R94-126 and R98-116 (Ehtesham
et al. 2002; Burns et al., in press), both of which
originated in Guam, the affected individuals were het-
erozygous for a mutation in the splice acceptor
(TAGrTGG) immediately preceding exon 8, predicting
skipping of exon 8 and a shift in the reading frame (fig.
4a). Skipping of the exon would lead to a protein with
an altered sequence after amino acid residue 207 and a
stop 62 codons later. The sequence change was inherited
from the fathers in both families. Affected individuals
in both families were also heterozygous for a point mu-
tation (GrA) that predicted an E87K substitution, an
acidic-to-basic charge change that was inherited from
their respective mothers (fig. 4a). Since the mothers in
both families share a chromosome 18 haplotype inher-
ited by their affected offspring, it is likely that this is
an ancestral mutation. Although we did not have access
to a population of ethnically matched individuals with
which to determine if the sequence change is a patho-
logical mutation or a polymorphism, like residue N469
described above, residue E87 is evolutionarily conserved
among homologous proteins in other species (fig. 3).
To determine if the splice-junctionmutation identified
in SMC led to exon skipping, total RNA from cartilage
of patient II-5 in family R94-126 and patient III-2 in
family R98-116 was used for amplification by RT-PCR
of a cDNA fragment spanning the exon. Comparedwith
control RNA, a normal-sized cDNA fragment and a
cDNA fragment of a size compatible with exon skipping
was amplified from each patient sample (fig. 4b). Se-
quence analysis of the smaller amplified fragment con-
firmed that the exon 8 sequences were missing from the
fragment, demonstrating that the mutation led to exon
skipping. The abundance of the shorter amplified frag-
ment was very much reduced relative to the normal-
sized product. To determine if this resulted from exon
skipping in only a proportion of transcripts derived
from the abnormal allele, a cDNA fragment spanning
both mutations was amplified, and gel electrophoresis
was used to separate the fragment of normal size from
the fragment with the skipped exon. Sequence analysis
in the region of the E87K mutation showed both the
mutant and normal sequences among the normal-sized
fragments, indicating that these fragments were derived
from both alleles (data not shown). Sequence analysis
across the skipped exon region showed that the normal-
sized fragments contained only the normal exon 8 se-
quence. These data demonstrated that exon skipping
was leaky and that some normal protein is likely to be
produced from the exon skipping allele.
The FLJ90130 cDNA predicts a 669-residue pro-
tein of unknown function. BLAST analysis of the pro-
tein sequence revealed highly homologous and thus
likely orthologous proteins in many species (fig. 3;
table 3), but in no species was a function ascribed to
the protein. Although DMC and SMC result in de-
fects in the brain and cartilage, database searching
has identified FLJ90130 transcripts derived from many
tissues, suggesting that the FLJ90130 gene is ubiqui-
tously expressed. These data, however, do not allow
assessment of the comparative level of expression
among tissues. Molecular modeling using the Tmpred
algorithm (Hofmann and Stoffel 1993) provided strong
evidence that FLJ90130 is a transmembrane protein
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Figure 3 Comparison of the protein sequences of FLJ90130 and homologous proteins in other species. ClustalWwas used for the alignment.
The species from which each sequence is derived is shown on the left (M. musculus [Mm], D. melanogaster [Dm], A. gambiae [Ag], C. elegans
[Ce], and A. thaliana [At]), and the amino acid residue numbers are shown on the right. Colors are used to indicate classes of amino acid
residues, including hydrophobic and aromatic (green), acidic (blue), basic (dark red), and hydrophilic (green) residues. Symbols below the amino
acid sequences indicate identity (*), presence of conserved substitutions (:), or presence of semiconserved substitutions (.). A gray background
highlights the residues changed by the two identified missense mutations, E87 and N469.
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Figure 4 Mutations in SMC. a, Chromatograms showing the two mutations identified in families R94-126 and R98-116. For the E87K
mutation, shown above, the reading frame is underlined, and the arrow identifies the normal (above) and mutant (below) sequences. For the
exon-skipping mutation, the smaller arrow identifies the normal (above) and mutant (below) sequences. The intron-exon junction is identified
with a vertical line and marked with the larger arrow. Segregation of the mutations in each family is shown on the pedigrees to the right. b,
Skipping of exon 8 in cartilage RNA from an affected member of each family. On the left, an image of the agarose gel used to separate the
amplified cDNA fragments from cartilage of patient II-5 in family R94-126 (“A”) and patient III-2 in family R98-116 (“B”), along with a
fragment derived from normal fetal cartilage (“C”). Fragment sizes are indicated to the left. The chromatogram on the right shows the sequence
across the exon 7/exon 9 boundary, which is identified by a vertical line, in the shorter cDNA fragment from patient II-5 in family R94-126.
with six transmembrane segments and a cytoplasmic
amino terminus. The six predicted membrane-spanning
regions, with the positions and/or consequences of the
identified mutations noted, are diagrammed in figure 5.
However, experimental verification will be required
both to test the hypothesis that FLJ90130 is located in
a membrane and to define the function of the protein
in the normal and disease states. In particular, it is likely
that the null mutations lead to mRNA instability and
no protein rather than a truncated protein.
Biochemical and morphologic data have suggested
the hypothesis that DMC and SMC may result from a
defect in proteoglycan metabolism (Engfeldt et al.
1983). The aggregated proteoglycan content of DMC
iliac crest cartilage was reduced, and there was a con-
comitant increase in monomeric proteoglycan, suggest-
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Figure 5 Structure of the FLJ90130 protein, with the six predicted transmembrane domains shown in yellow. The beginning and ending
residues of each transmembrane segment are indicated. Shown below are the predicted consequences of each mutation on the protein sequence/
structure in the three DMC and two SMC families studied. Where the mutation results in a frameshift, the portion of the protein beyond the
frameshift is indicated in red. The locations of missense mutations are identified with a dot and the specific protein-sequence change.
ing that altered glycosaminoglycan function is a feature
of DMC. Cartilage histology in both SMC and DMC
have demonstrated thickened collagen fibrils, compat-
ible with a possible deficiency in matrix glycoproteins
(Horton et al. 1982; Engfeldt et al. 1983; Nakamura et
al. 1997), which are known to regulate collagen fibril
formation (Chandrasekhar et al. 1984; Vogel and Trot-
ter 1987; Kuijer et al. 1988; Neame et al. 2000). Since
normal proteoglycan biosynthesis is critical for elabo-
ration of the extracellular matrix of cartilage and the
brain, the hypothesis that FLJ90130 encodes a protein
that participates in proteoglycan metabolism is attrac-
tive. The high demand for proteoglycan synthesis in
cartilage and brain could also explain why the pheno-
type is predominantly expressed in these tissues.
We conclude that SMC and DMC are allelic disorders
that result from mutations in the FLJ90130 gene. The
data thus lay to rest the question of whether these two
disorders result from mutations in the same gene. DMC
appears to result from absence of the FLJ90130 gene
product, implying that at least one mutant allele in the
SMC patients encodes a protein with partial function.
The FLJ90130 gene may encode a membrane protein
that participates in proteoglycan metabolism, specula-
tion that is supported by the recessive inheritance pat-
tern of the disease, the biochemical and histological
findings in SMC and DMC cartilage, and the prominent
role of proteoglycans in the two tissues most affected
in these disorders, cartilage and the brain.
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